Cite
HARVARD Citation
Su, C. et al. (2023). Differential responses to taxanes and PARP inhibitors in ATM‐ versus BRCA2‐mutated metastatic castrate‐resistant prostate cancer. Prostate. 83 (3), pp. 227-236. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Su, C. et al. (2023). Differential responses to taxanes and PARP inhibitors in ATM‐ versus BRCA2‐mutated metastatic castrate‐resistant prostate cancer. Prostate. 83 (3), pp. 227-236. [Online].